Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Measurement of lymphatic flow variation by noninvasive method cases of lymphedema.

Identifieur interne : 002007 ( Ncbi/Merge ); précédent : 002006; suivant : 002008

Measurement of lymphatic flow variation by noninvasive method cases of lymphedema.

Auteurs : G. Thibaut [France] ; A. Durand ; P. Follignoni ; A. Bertrand

Source :

RBID : pubmed:1626734

Descripteurs français

English descriptors

Abstract

The purpose of this study was to measure the variations of lymphatic flow. A noninvasive isotopic method was used to achieve a functional exploration of lymphatic circulation. Fifteen subjects were used in the study: 10 healthy subjects and 5 patients with lower extremity lymphedema. A first subcutaneous injection of technetium 99m rhenium sulfate (99mTc) was performed in the first interdigital space of both feet. The radioactivity was recorded in two places: the first one on the inguinal site by a gamma camera; the second, below the first, on the precordial site by a multichannel analyzer. With the two types of recording procedures, it was possible to obtain a curve that showed the amount of radioactivity in relation to time. In order to obtain a muscular activity fifty-five minutes after the injection, each subject or patient spent ten minutes on an ergometric bike. A second subcutaneous injection was performed one week later, but prior to the injection, the subject or patient took orally 1800 mg of heptaminol adenosine phosphate (HAP) per day for three days. The radioactivity recording was made under the same conditions as with the muscular activity. The statistical results of the experiment without treatment on the two types of recording show that in the healthy subjects the amount of radioactivity increased during muscular activity. Moreover, the treatment indicated higher radioactivity values, which remained at a higher level. However, the muscular activity performed by a patient was unable to increase the radioactivity. On the other hand, the drug gave radioactivity values that were higher than the previous values of the first curve.(ABSTRACT TRUNCATED AT 250 WORDS)

DOI: 10.1177/000331979204300704
PubMed: 1626734

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:1626734

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Measurement of lymphatic flow variation by noninvasive method cases of lymphedema.</title>
<author>
<name sortKey="Thibaut, G" sort="Thibaut, G" uniqKey="Thibaut G" first="G" last="Thibaut">G. Thibaut</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service des Urgences, Vandoeuvre-Les-Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service des Urgences, Vandoeuvre-Les-Nancy</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Vandœuvre-lès-Nancy</settlement>
<settlement type="city" wicri:auto="agglo">Nancy</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Durand, A" sort="Durand, A" uniqKey="Durand A" first="A" last="Durand">A. Durand</name>
</author>
<author>
<name sortKey="Follignoni, P" sort="Follignoni, P" uniqKey="Follignoni P" first="P" last="Follignoni">P. Follignoni</name>
</author>
<author>
<name sortKey="Bertrand, A" sort="Bertrand, A" uniqKey="Bertrand A" first="A" last="Bertrand">A. Bertrand</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1992">1992</date>
<idno type="RBID">pubmed:1626734</idno>
<idno type="pmid">1626734</idno>
<idno type="doi">10.1177/000331979204300704</idno>
<idno type="wicri:Area/PubMed/Corpus">005904</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005904</idno>
<idno type="wicri:Area/PubMed/Curation">005904</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005904</idno>
<idno type="wicri:Area/PubMed/Checkpoint">005904</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005904</idno>
<idno type="wicri:Area/Ncbi/Merge">002007</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Measurement of lymphatic flow variation by noninvasive method cases of lymphedema.</title>
<author>
<name sortKey="Thibaut, G" sort="Thibaut, G" uniqKey="Thibaut G" first="G" last="Thibaut">G. Thibaut</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service des Urgences, Vandoeuvre-Les-Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service des Urgences, Vandoeuvre-Les-Nancy</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Vandœuvre-lès-Nancy</settlement>
<settlement type="city" wicri:auto="agglo">Nancy</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Durand, A" sort="Durand, A" uniqKey="Durand A" first="A" last="Durand">A. Durand</name>
</author>
<author>
<name sortKey="Follignoni, P" sort="Follignoni, P" uniqKey="Follignoni P" first="P" last="Follignoni">P. Follignoni</name>
</author>
<author>
<name sortKey="Bertrand, A" sort="Bertrand, A" uniqKey="Bertrand A" first="A" last="Bertrand">A. Bertrand</name>
</author>
</analytic>
<series>
<title level="j">Angiology</title>
<idno type="ISSN">0003-3197</idno>
<imprint>
<date when="1992" type="published">1992</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adenosine Monophosphate (administration & dosage)</term>
<term>Adenosine Monophosphate (analogs & derivatives)</term>
<term>Heptaminol (administration & dosage)</term>
<term>Heptaminol (analogs & derivatives)</term>
<term>Humans</term>
<term>Leg (diagnostic imaging)</term>
<term>Lymph (physiology)</term>
<term>Lymphedema (diagnostic imaging)</term>
<term>Lymphedema (physiopathology)</term>
<term>Physical Exertion</term>
<term>Radionuclide Imaging</term>
<term>Rhenium</term>
<term>Technetium Tc 99m Sulfur Colloid</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>AMP (administration et posologie)</term>
<term>AMP (analogues et dérivés)</term>
<term>Effort physique</term>
<term>Heptaminol (administration et posologie)</term>
<term>Heptaminol (analogues et dérivés)</term>
<term>Humains</term>
<term>Jambe (imagerie diagnostique)</term>
<term>Lymphe (physiologie)</term>
<term>Lymphoedème (imagerie diagnostique)</term>
<term>Lymphoedème (physiopathologie)</term>
<term>Rhénium</term>
<term>Scintigraphie</term>
<term>Sulfocolloïde de technétium (99mTc)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Adenosine Monophosphate</term>
<term>Heptaminol</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Adenosine Monophosphate</term>
<term>Heptaminol</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>AMP</term>
<term>Heptaminol</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr">
<term>AMP</term>
<term>Heptaminol</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en">
<term>Leg</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr">
<term>Jambe</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Lymphe</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Lymph</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr">
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Physical Exertion</term>
<term>Radionuclide Imaging</term>
<term>Rhenium</term>
<term>Technetium Tc 99m Sulfur Colloid</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Effort physique</term>
<term>Humains</term>
<term>Rhénium</term>
<term>Scintigraphie</term>
<term>Sulfocolloïde de technétium (99mTc)</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The purpose of this study was to measure the variations of lymphatic flow. A noninvasive isotopic method was used to achieve a functional exploration of lymphatic circulation. Fifteen subjects were used in the study: 10 healthy subjects and 5 patients with lower extremity lymphedema. A first subcutaneous injection of technetium 99m rhenium sulfate (99mTc) was performed in the first interdigital space of both feet. The radioactivity was recorded in two places: the first one on the inguinal site by a gamma camera; the second, below the first, on the precordial site by a multichannel analyzer. With the two types of recording procedures, it was possible to obtain a curve that showed the amount of radioactivity in relation to time. In order to obtain a muscular activity fifty-five minutes after the injection, each subject or patient spent ten minutes on an ergometric bike. A second subcutaneous injection was performed one week later, but prior to the injection, the subject or patient took orally 1800 mg of heptaminol adenosine phosphate (HAP) per day for three days. The radioactivity recording was made under the same conditions as with the muscular activity. The statistical results of the experiment without treatment on the two types of recording show that in the healthy subjects the amount of radioactivity increased during muscular activity. Moreover, the treatment indicated higher radioactivity values, which remained at a higher level. However, the muscular activity performed by a patient was unable to increase the radioactivity. On the other hand, the drug gave radioactivity values that were higher than the previous values of the first curve.(ABSTRACT TRUNCATED AT 250 WORDS)</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">1626734</PMID>
<DateCreated>
<Year>1992</Year>
<Month>08</Month>
<Day>07</Day>
</DateCreated>
<DateCompleted>
<Year>1992</Year>
<Month>08</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>02</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0003-3197</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>43</Volume>
<Issue>7</Issue>
<PubDate>
<Year>1992</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Angiology</Title>
<ISOAbbreviation>Angiology</ISOAbbreviation>
</Journal>
<ArticleTitle>Measurement of lymphatic flow variation by noninvasive method cases of lymphedema.</ArticleTitle>
<Pagination>
<MedlinePgn>567-71</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The purpose of this study was to measure the variations of lymphatic flow. A noninvasive isotopic method was used to achieve a functional exploration of lymphatic circulation. Fifteen subjects were used in the study: 10 healthy subjects and 5 patients with lower extremity lymphedema. A first subcutaneous injection of technetium 99m rhenium sulfate (99mTc) was performed in the first interdigital space of both feet. The radioactivity was recorded in two places: the first one on the inguinal site by a gamma camera; the second, below the first, on the precordial site by a multichannel analyzer. With the two types of recording procedures, it was possible to obtain a curve that showed the amount of radioactivity in relation to time. In order to obtain a muscular activity fifty-five minutes after the injection, each subject or patient spent ten minutes on an ergometric bike. A second subcutaneous injection was performed one week later, but prior to the injection, the subject or patient took orally 1800 mg of heptaminol adenosine phosphate (HAP) per day for three days. The radioactivity recording was made under the same conditions as with the muscular activity. The statistical results of the experiment without treatment on the two types of recording show that in the healthy subjects the amount of radioactivity increased during muscular activity. Moreover, the treatment indicated higher radioactivity values, which remained at a higher level. However, the muscular activity performed by a patient was unable to increase the radioactivity. On the other hand, the drug gave radioactivity values that were higher than the previous values of the first curve.(ABSTRACT TRUNCATED AT 250 WORDS)</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Thibaut</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Service des Urgences, Vandoeuvre-Les-Nancy, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Durand</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Follignoni</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bertrand</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Angiology</MedlineTA>
<NlmUniqueID>0203706</NlmUniqueID>
<ISSNLinking>0003-3197</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C030406">technetium Tc rhenium-sulfur colloid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>3DQS188SY5</RegistryNumber>
<NameOfSubstance UI="D006535">Heptaminol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>415SHH325A</RegistryNumber>
<NameOfSubstance UI="D000249">Adenosine Monophosphate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>556Q0P6PB1</RegistryNumber>
<NameOfSubstance UI="D013671">Technetium Tc 99m Sulfur Colloid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>57249-13-5</RegistryNumber>
<NameOfSubstance UI="C053918">heptaminol AMP amidate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-15-5</RegistryNumber>
<NameOfSubstance UI="D012211">Rhenium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000249" MajorTopicYN="N">Adenosine Monophosphate</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006535" MajorTopicYN="N">Heptaminol</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007866" MajorTopicYN="N">Leg</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008196" MajorTopicYN="N">Lymph</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005082" MajorTopicYN="N">Physical Exertion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011877" MajorTopicYN="N">Radionuclide Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012211" MajorTopicYN="N">Rhenium</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013671" MajorTopicYN="N">Technetium Tc 99m Sulfur Colloid</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1992</Year>
<Month>7</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1992</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1992</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">1626734</ArticleId>
<ArticleId IdType="doi">10.1177/000331979204300704</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Grand Est</li>
<li>Lorraine (région)</li>
</region>
<settlement>
<li>Nancy</li>
<li>Vandœuvre-lès-Nancy</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Bertrand, A" sort="Bertrand, A" uniqKey="Bertrand A" first="A" last="Bertrand">A. Bertrand</name>
<name sortKey="Durand, A" sort="Durand, A" uniqKey="Durand A" first="A" last="Durand">A. Durand</name>
<name sortKey="Follignoni, P" sort="Follignoni, P" uniqKey="Follignoni P" first="P" last="Follignoni">P. Follignoni</name>
</noCountry>
<country name="France">
<region name="Grand Est">
<name sortKey="Thibaut, G" sort="Thibaut, G" uniqKey="Thibaut G" first="G" last="Thibaut">G. Thibaut</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002007 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002007 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:1626734
   |texte=   Measurement of lymphatic flow variation by noninvasive method cases of lymphedema.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:1626734" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024